|
|
|
Welcome to the Author Digest We hope you find it helpful. This digest goes out to all active Cochrane authors and will continue to be sent to authors who are opted in. Please review your communication preferences in your Cochrane Account and ensure you are opted in to communications.
|
|
|
|
|
|
Contents - Cochrane's new scientific strategy
- Changes coming to RevMan - new Project Management features
- What are our Methods reviewers looking for?
- Cochrane Methods Week is happening November 18-22!
- Equity in all Cochrane reviews: upcoming web clinic
- Introducing ROB-ME: a tool for assessing risk of non-reporting biases in systematic reviews with meta-analysis
- Top tips
|
|
|
|
|
1. Cochrane's new scientific strategy
|
|
|
Cochrane has announced a new scientific strategy to tackle the most pressing global health challenges driving inequity. This strategy focuses on key research priorities, including maternal, newborn and child health, chronic conditions, infectious diseases, and climate change and sustainability. It is underpinned by commitments to innovation, collaboration, championing research integrity, and promoting health equity. Discover more about Cochrane's vision for a healthier, more equitable world.
https://www.cochrane.org/about-us/scientific-strategy
|
|
|
|
|
2. Changes coming to RevMan - new Project Management features
|
|
|
In November and early December, Cochrane protocols and reviews will have new features on the Dashboard to help you manage your progress on your review. Please register for our Learning Live webinar to learn more about how you can use these features. This webinar will provide a comprehensive overview of all essential project management functionality (e.g. getting started, new functionalities in RevMan, tasks and milestones, decision log). The session is of particular interest to Cochrane authors, anyone interested in becoming a Cochrane author, staff in groups supporting authors as well as non-Cochrane authors/users of RevMan.
It will be held on Tuesday 3rd December at two different times to cover global time zones.
|
|
|
|
|
3.What are our Methods reviewers looking for?
|
|
|
Quality Assurance Editors in Cochrane Central Editorial Service assess the methods of all submitted protocols and reviews against a methods checklist. We have now made these checklists freely available. View the checklist for protocols and checklist for reviews. These checklists are a great resource to help you assess your own work before submission. They are primarily for intervention reviews, but some checks are relevant to all review types. QA Editors may continue to revise and update the checklists when necessary. The latest versions will always be available at the links shown (also linked from our Author guidelines).
If you have questions about your review after having reviewed the checklists, please firstly revisit the Core methods and policies section in our Author guidelines. If you still have questions, please reach out to support@cochrane.org.
|
|
|
|
|
4. Cochrane Methods Week is happening November 18-22!
|
|
|
Join us on Cochrane's X, LinkedIn, and Instagram accounts for a week filled with resources, quizzes, and opportunities to get involved. Don’t miss this chance to learn from Cochrane experts and enhance your understanding of evidence synthesis methods!
|
|
|
|
|
5. Equity in all Cochrane reviews: upcoming web clinic
|
|
|
The new Cochrane review format includes headings for describing how authors will consider health equity. In this web clinic, Jennifer Petkovic and Jordi Pardo Pardo from the Cochrane Health Equity Thematic Group will provide an introduction to health equity and describe how to consider and report on equity within the new sections of Cochrane protocols and reviews. The clinic is freely available to all and will take place at 14.00 UTC on Thursday 14th November.
|
|
|
|
|
6. Introducing ROB-ME: a tool for assessing risk of non-reporting biases in systematic reviews with meta-analysis
|
|
|
The recording is now available of the October Methods Support Unit web clinic which focused on ROB-ME. Researchers’ decisions about whether, when, how or where to report studies or results are often influenced by the P value, magnitude or direction of the study results (‘non-reporting biases’). A consequence is bias in meta-analyses, because the available evidence differs systematically from the missing evidence. In this web clinic, the presenters introduced ROB-ME (“Risk Of Bias due to Missing Evidence”), a comprehensive tool for assessing the risk of bias that arises when entire studies, or particular results within studies, are missing from a meta-analysis because of the P value, magnitude, or direction of the study results.
|
|
|
|
|
7. Top tips for Cochrane Authors
|
|
|
|
|
|
What is study centric data management? Study centric data management is an innovative, time-saving approach to managing data in your review. - Set up your synthesis criteria and analyses in RevMan in advance (at protocol stage)
- Extract data in Covidence or using our recommended templates
- Import your study data in a few clicks
- Automatically add data to populate your analyses - avoiding manual data entry errors
Read more about study centric data management in the RevMan Knowledge Base
|
|
|
|
|
|
|
